|
1
|
American Cancer Society: Cancer Facts
& Figures. 2011, Atlanta: American Cancer Society; 2011
|
|
2
|
Bergstrom A, Pisani P, Tenet V, Wolk A and
Adami HO: Overweight as an avoidable cause of cancer in Europe. Int
J Cancer. 91:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calle EE and Kaaks R: Overweight, obesity
and cancer: epidemiological evidence and proposed mechanisms. Nat
Rev Cancer. 4:579–591. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farrow DC, Weiss NS, Lyon JL and Daling
JR: Association of obesity and ovarian cancer in a case-control
study. Am J Epidemiol. 129:1300–1304. 1989.PubMed/NCBI
|
|
5
|
Leitzmann MF, Koebnick C, Danforth KN, et
al: Body mass index and risk of ovarian cancer. Cancer.
115:812–822. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levi F, La Vecchia C, Negri E, Parazzini F
and Franceschi S: Body mass at different ages and subsequent
endometrial cancer risk. Int J Cancer. 50:567–571. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lew EA and Garfinkel L: Variations in
mortality by weight among 750,000 men and women. J Chronic Dis.
32:563–576. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lukanova A, Lundin E, Micheli A, et al:
Circulating levels of sex steroid hormones and risk of endometrial
cancer in postmenopausal women. Int J Cancer. 108:425–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Risch HA: Hormonal etiology of epithelial
ovarian cancer, with a hypothesis concerning the role of androgens
and progesterone. J Natl Cancer Inst. 90:1774–1786. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vona-Davis L and Rose DP: Adipokines as
endocrine, paracrine, and autocrine factors in breast cancer risk
and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gonzalez RR, Simon C, Caballero-Campo P,
et al: Leptin and reproduction. Hum Reprod Update. 6:290–300. 2000.
View Article : Google Scholar
|
|
12
|
Greisen S, Ledet T, Moller N, et al:
Effects of leptin on basal and FSH stimulated steroidogenesis in
human granulosa luteal cells. Acta Obstet Gynecol Scand.
79:931–935. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hamann A and Matthaei S: Regulation of
energy balance by leptin. Exp Clin Endocrinol Diabetes.
104:293–300. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashizawa N, Yahata T, Quan J, et al: Serum
leptin-adiponectin ratio and endometrial cancer risk in
postmenopausal female subjects. Gynecol Oncol. 119:65–69. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cymbaluk A, Chudecka-Glaz A and
Rzepka-Gorska I: Leptin levels in serum depending on body mass
index in patients with endometrial hyperplasia and cancer. Eur J
Obstet Gynecol Reprod Biol. 136:74–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mor G, Visintin I, Lai Y, et al: Serum
protein markers for early detection of ovarian cancer. Proc Natl
Acad Sci USA. 102:7677–7682. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Tian J, Lv Y, et al: Leptin induces
functional activation of cyclooxygenase-2 through JAK2/STAT3,
MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
Cancer Sci. 100:389–395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uddin S, Bu R, Ahmed M, et al:
Overexpression of leptin receptor predicts an unfavorable outcome
in Middle Eastern ovarian cancer. Mol Cancer. 8:742009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lang K and Ratke J: Leptin and
adiponectin: new players in the field of tumor cell and leukocyte
migration. Cell Commun Signal. 7:272009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bjorbaek C, Uotani S, da Silva B and Flier
JS: Divergent signaling capacities of the long and short isoforms
of the leptin receptor. J Biol Chem. 272:32686–32695. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bogusiewicz M, Semczuk A, Gogacz M, et al:
Lack of correlation between leptin receptor expression and
PI3-K/Akt signaling pathway proteins immunostaining in
endometrioid-type endometrial carcinomas. Cancer Lett. 238:61–68.
2006. View Article : Google Scholar
|
|
22
|
Yuan SS, Tsai KB, Chung YF, et al:
Aberrant expression and possible involvement of the leptin receptor
in endometrial cancer. Gynecol Oncol. 92:769–775. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kurman RJ and Shih IeM: The origin and
pathogenesis of epithelial ovarian cancer: a proposed unifying
theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noyes RW, Hertig AT and Rock J: Dating the
endometrial biopsy. Am J Obstet Gynecol. 122:262–263.
1975.PubMed/NCBI
|
|
25
|
Silverberg SG, Mutter GL, Kurman RJ,
Kubik-Huch RA, Nogales F and Tavassoli FA: Tumors of the uterine
corpus: epithelial tumors and related lesions. WHO Classification
of Tumors: Pathology and Genetics of Tumors of the Breast and
Female Genital Organs. Tavassoli FA and Devilee P: IARC Press;
Lyon: pp. 221–232. 2003
|
|
26
|
Ruifrok AC and Johnston DA: Quantification
of histochemical staining by color deconvolution. Anal Quant Cytol
Histol. 23:291–299. 2001.PubMed/NCBI
|
|
27
|
Cornish TC and Haluska MK: Color
deconvolution for the analysis of tissue microarrays. Anal Quant
Cytol Histol. 31:304–312. 2009.PubMed/NCBI
|
|
28
|
Koda M, Sulkowska M, Wincewicz A, et al:
Expression of leptin, leptin receptor, and hypoxia-inducible factor
1 alpha in human endometrial cancer. Ann NY Acad Sci. 1095:90–98.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wincewicz A, Koda M, Sulkowska M,
Kanczuga-Koda L and Sulkowski S: Comparison of STAT3 with
HIF-1alpha, Ob and ObR expressions in human endometrioid
adenocarcinomas. Tissue Cell. 40:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kitawaki J, Koshiba H, Ishihara H, et al:
Expression of leptin receptor in human endometrium and fluctuation
during the menstrual cycle. J Clin Endocrinol Metab. 85:1946–1950.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Johnson CW: Issue in immunohistochemistry.
Toxicol Pathol. 27:246–248. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cross SS: Observer accuracy in estimating
proportions in images: implications for the semiquantitative
assessment of staining reactions and a proposal for a new system. J
Clin Pathol. 54:385–390. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Diaz LK and Sneige N: Estrogen receptor
analysis for breast cancer: current issues and keys to increasing
testing accuracy. Adv Anat Pathol. 12:10–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ
and Gown AM: Quantitative evaluation of HER-2/neu status in breast
cancer by fluorescence in situ hybridization and by
immunohistochemistry with image analysis. Am J Clin Pathol.
115:814–822. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Umemura S, Itoh J, Itoh H, et al:
Immunohistochemical evaluation of hormone receptors in breast
cancer: which scoring system is suitable for highly sensitive
procedures? Appl Immunohistochem Mol Morphol. 12:8–13. 2004.
View Article : Google Scholar : PubMed/NCBI
|
